
David van Duin
@davidvanduin
Infectious Diseases doc with interests in multi-drug resistant Gram-negative bacteria, and transplant, hem/onc, and burn patients. Opinions are my own.
ID: 2342533784
13-02-2014 20:22:56
5,5K Tweet
4,4K Followers
1,1K Following

Important One Health perspective on #antimicrobialresistance Sid Thakur

TxID Early Career Network Infectious Diseases Community of Practice - AST Ricardo M. La Hoz Ann Woolley This study looks to be quite well done; the authors say that “the results are not generalizable to patients who are immunocompromised”, in whom this can be a devastating, life-threatening infection. I have not had trouble giving four doses of ivermectin.





Nice work by Dylan Brown (starting Med school at Hofstra University in fall👍👍): Socioeconomic disparities in the prevalence of multidrug resistance in Enterobacterales | Infection Control & Hospital Epidemiology | Cambridge Core cambridge.org/core/journals/…






Here is a brief twetorial on test taking strategies and how to approach a multiple choice question. New to posting twetorials & twitter threads, so would love feedback from Twitter gurus Paul Sax Carlos del Rio David van Duin IDSA

Kakooza et al. report high prevalence of resistance to ciprofloxacin, tetracycline and benzylpenicillin, and emerging resistance determinants for azithromycin, in gonococcal isolates from African countries: doi.org/10.1093/jac/dk… OUP Medicine Oxford Journals #JACNews

“Resistance of Acinetobacter baumannii to the recently available cefiderocol is concerning. Sulbactam/durlobactam is a promising option for MDR A. baumannii” Read the article by Tiseo et al: doi.org/10.1093/jacamr… @OUPMedicine Oxford Journals #JACNews

A behind the scenes look at Tuesday’s congressional hearing on #antimicrobialresistance. Take action on the PASTEUR Act. Your voice will push Congress to create programs to help fight against AMR: idsociety.quorum.us/campaign/47463/ Senate HELP Committee GOP HELP Committee Dems Helen Boucher
